Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy |
Extensive-stage Small Cell Lung Cancer (ES-SCLC) | Phase1, Phase2 | Singapore | NCT07564401 |
A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients |
Familial Mediterranean Fever, Still Disease, Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still Disease | Switzerland | NCT07517250 | |
A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany |
Leukemia, Chronic Myeloid | Germany | NCT07549516 | |
Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment |
Advanced Malignancies and Hepatic Impairment | Phase1 | United Kingdom | NCT07422610 |
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer |
Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase1 | Australia United States |
NCT07570979 |
Remibrutinib Open Label Roll-over Post-trial Access Protocol |
Indication of the Parent Protocol | Phase3 | Canada South Korea |
NCT07456891 |
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy |
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) | Phase3 | Germany United States |
NCT07498426 |
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) |
Primary Immune Thrombocytopenia (ITP), Primary Evans Syndrome (ES) | Phase2 | United States | NCT07421167 |
Pediatric Long-Term Follow-up and Rollover Study |
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma, Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, Angiocentric Glioma, Chordoid Glioma of Third Ventricle, Gangliocytoma, Ganglioglioma, Anaplastic Ganglioglioma, Dysplastic Gangliocytoma of Cerebrellum, Desmoplastic Infantile Astrocytoma and Ganglioglioma, Papillary Glioneuronal Tumor, Rosette-forming Glioneuronal Tumor, Central Neurocytoma, Extraventricular Neurocytoma, Cerebellar Liponeurocytoma, Neurofibromatosis Type 1 | Phase4 | Germany Israel United States |
NCT03975829 |
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies |
Heterozygous or Homozygous Familial Hypercholesterolemia | Phase3 | Taiwan | NCT05682378 |